A Metabolic Intravascular Platform to Study FDG Uptake in Vascular Injury
F Franchi1, M Olthoff2, J Krier3
1Department of Cardiovascular Medicine, Mayo Clinic School of Medicine Rochester, Mayo Clinic, 200 First St SW, Rochester, MN, 55902, USA. Franchi.Federico@mayo.edu.
Cardiovascular Engineering and Technology
|February 1, 2020
Summary
Researchers developed a sensitive metabolic sensor to detect vascular inflammation in vivo. This platform shows promise for identifying macrophage activity and other disease processes, advancing metabolic research closer to clinical applications.
Area of Science:
- Biomedical Engineering
- Molecular Imaging
- Metabolic Research
Background:
- Metabolic alterations are key in many diseases, necessitating advanced in vivo assessment methods.
- Current molecular imaging allows in vivo metabolic studies but often requires proximity to target organs, like in vascular metabolism research.
Purpose of the Study:
- To develop and validate a sensitive metabolic detection platform for in vivo studies of vascular metabolism.
- To assess the platform's ability to detect inflammation by monitoring macrophage activity.
Main Methods:
- A scintillating fiber sensor coupled with a photomultiplier tube and tunable analysis platform was developed.
- In vivo validation used New Zealand rabbits with induced inflammation (high cholesterol diet or endothelial denudation).
- Experiments focused on macrophage metabolic activity, utilizing 18F-fluorodeoxyglucose (18F-FDG) uptake.
Main Results:
- The metabolic sensor detected vascular inflammation (0.60 ± 0.03 AU vs. control 0.48 ± 0.03 AU, p=0.01).
- The sensor demonstrated higher sensitivity than intravascular ultrasound in detecting inflammation.
- Ex vivo tissue staining confirmed the presence of macrophages in inflamed areas.
Conclusions:
- A tunable, highly sensitive metabolic sensor platform for in vivo vascular metabolism detection, including inflammation, was successfully validated.
- The sensor can detect macrophage activity and, with alternative probes, other pathophysiological processes.
- This technology advances metabolic research and brings in vivo diagnostics closer to patient application.
![Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography FDG-PET/CT](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F3777.jpg&w=3840&q=50)

![Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58641.jpg&w=3840&q=50)